Done sou Salè H1B

Akèy › Anplwayè › Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc.: Salè H-1B ak pajon

Dyne Therapeutics, Inc. depoze 19 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 18. Medyèn salè yo ofri a: $172,000.

Demann (LCA)19
Certifye18
Adrès anplwayèWaltham, MA
Anplwayè H-1B depannNon
Salè medyan ofri$172,000
Mwatye salè yo$123,500–$211,316
10yèm–90yèm pousantaj$116,100–$247,500

Èske Dyne Therapeutics, Inc. pajone visa H-1B?

Dyne Therapeutics, Inc. depoze 19 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 1, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.

Salè pa tit travay

Tit travayLCASalè medyan
Associate Director, Clinical Operations Study Lead2$185,625
Director, Analytical Development/Quality Control (QC)2$211,755
Director, Drug Safety & Pharmacovigilance Scientist2$237,500
Associate Director, Statistical Programming2$207,500
Senior Research Associate, Platform Development1$105,256
Senior Director, Regulatory Information Management1$265,000
Senior Research Associate1$114,862
Senior Manager, Analytical Development and Quality Control1$169,000
Senior Research Associate, RNA Chemistry1$123,000
Senior Director, Scientific & Medical Education1$275,000
Senior Research Associate, CMC Process Sciences1$116,630
Senior Associate, Senior Engineer Information Security1$120,000
Scientist, Platform Development1$125,000
Scientist, Genetic Medicines Research1$135,750
Scientist, Platform Discovery1$141,010

Aplikasyon pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$175,000
FY20247$146,000
FY20256$167,500
FY20265$196,250

Nivo salè prevanlan

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Kote travay yo ye

Okipasyon

Dènye aplikasyon yo

Tit travaySalè bazKoteSoumètDat kòmansmanEstati
Associate Director, Clinical Operations Study Lead$196,250Waltham, MAMay 1, 2026Jun 19, 2026Certifye
Scientist, Genetic Medicines Research$135,750
Nivo II
Waltham, MAApr 21, 2026Oct 1, 2026Certifye
Scientist, Platform Discovery$141,010
Nivo II
Waltham, MAApr 21, 2026Oct 1, 2026Certifye
Associate Director, Statistical Programming$205,000
Nivo III
Waltham, MAApr 21, 2026May 11, 2026Certifye
Director, Drug Safety & Pharmacovigilance Scientist$235,000
Nivo IV
Waltham, MANov 4, 2025Nov 12, 2025Certifye
Director, Drug Safety & Pharmacovigilance Scientist$240,000
Nivo IV
Waltham, MAJul 22, 2025Aug 11, 2025Certifye
Associate Director, Statistical Programming$210,000
Nivo IV
Waltham, MAJun 26, 2025Jul 21, 2025Certifye
Senior Research Associate, CMC Process Sciences$116,630
Nivo II
Waltham, MAMay 20, 2025Jul 1, 2025Certifye
Senior Director, Scientific & Medical Education$275,000
Nivo IV
Waltham, MAMay 20, 2025Jun 30, 2025Certifye
Scientist, Platform Development$125,000
Nivo II
Waltham, MAApr 30, 2025Oct 1, 2025Certifye
Senior Associate, Senior Engineer Information Security$120,000
Nivo II
Waltham, MAApr 30, 2025Oct 1, 2025Certifye
Senior Manager, Analytical Development and Quality Control$169,000
Nivo III
Waltham, MAAug 21, 2024Nov 14, 2024Certifye
Senior Research Associate, RNA Chemistry$123,000
Nivo II
Waltham, MAJul 8, 2024Jul 26, 2024Certifye
Senior Director, Regulatory Information Management$265,000
Nivo IV
Waltham, MAJun 11, 2024Jul 8, 2024Certifye
Senior Research Associate$114,862
Nivo I
Waltham, MAApr 25, 2024Sep 30, 2024Certifye
Senior Research Associate, Platform Development$105,256
Nivo II
Waltham, MAMar 19, 2024Apr 18, 2024Certifye
Director, Analytical Development/Quality Control (QC)$211,755
Nivo IV
Waltham, MADec 13, 2023Mar 31, 2024Certifye
Director, Analytical Development/Quality Control (QC)$211,775
Nivo IV
Waltham, MADec 12, 2023Mar 31, 2024Retire
Associate Director, Clinical Operations Study Lead$175,000Waltham, MAMay 23, 2023Jun 20, 2023Certifye

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).